Healthcare

Medical Simulation Market by Product & Service (Model-based Simulation, Web-based simulation, and Simulation Training Services), Fidelity (Low-fidelity, Medium-fidelity, and High-Fidelity), and End User (Academic Institutes and Research Centers, Hospitals & Clinics, and Military Organizations): Global Opportunity Analysis and Industry Forecast, 2018–2025

  • ALL3237292
  • 216 Pages
  • June 2019
  • Healthcare
Download Sample    Get Discount   
 
Medical simulation is the virtual duplication of in situ activities or phenomenon, representing the functions and properties of a selective real abstract or process. It is used to train healthcare professionals using advanced healthcare technologies.

The global medical simulation market was valued at $1,132 million in 2017 and is estimated to reach $ 3,251 million by 2025, registering a CAGR of 14.0% from 2018 to 2025. The global medical simulation market is driven by the increase in use of simulation in healthcare, rise in deaths due to medical errors, and necessity to improve patient safety outcomes. Moreover, the benefits of medical simulation such as training of complex as well as normal cases for professionals and technological advancements in medical field further increase the demand for medical simulation. However, high installation cost and lack of complete real situation restrain the market growth.

The global medical simulation market is segmented based on product & service, fidelity, end user, and region. Based on product & service, it is divided into model-based simulation, web-based simulation, and simulation training services. Model-based simulation is further classified into patient simulation, surgical simulation, and ultrasound simulation. Patient simulation is segmented into task trainers, manikin-based simulators, and standardized patient simulators. Surgical simulation is sub-segmented in laparoscopic surgical simulators, arthroscopic surgical simulators, cardiovascular simulators, gynecology simulators, and others. Web-based simulation segment is classified into simulation software, performance-recording software, and virtual tutors. Simulation training services comprise vendor-based training services, custom consulting services, and educational society services. Based on fidelity, the market is classified into low-fidelity, medium fidelity, and high-fidelity simulators. Based on end user, the market is divided into academic institutions & research centers, hospitals & clinics, and military organizations. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

• This report provides an extensive analysis of the emerging trends and dynamics in the global medical simulation market.

• This study provides the landscape of the global market to predict the competitive environment across geographies.

• This report entails the detailed quantitative analyses of the current trends and future estimations to identify the prevailing opportunities.

• Comprehensive analyses of factors that drive and restrict the market growth is provided in the report.

• Region- and country-wise analysis is conducted to understand the market trends and dynamics.

KEY MARKET SEGMENTS

• By Product & Service

o Model-based Simulation

 Patient Simulation

• Task Trainer Simulation

• Manikin-based Simulation

• Standardized Patient Simulation

 Surgical Simulation

• Laparoscopic Surgical Simulators

• Arthroscopic Surgical Simulators

• Cardiovascular Simulators

• Gynecology Simulators

• Others

 Ultrasound Simulation

o Web-based Simulation

 Simulation Software

 Performance-Recording Software

 Virtual Tutors

o Simulation Training Services

 Vendor-based Training

 Custom Consulting Services

 Educational Societies

• By Fidelity

o Low-fidelity

o Medium-fidelity

o High-fidelity

• By End User

o Academic Institutions & Research Centers

o Hospitals & Clinics

o Military Organizations

• By Region

o North America

 U.S.

 Canada

 Mexico

o Europe

 Germany

 France

 UK

 Italy

 Spain

 Rest of Europe

o Asia-Pacific

 Japan

 China

 India

 Australia

 Rest of Asia-Pacific

o LAMEA

 Brazil

 Saudi Arabia

 South Africa

 Rest of LAMEA

The key players profiled in this report are as follows:

• Laerdal Medical AS

• CAE, Inc.

• 3D Systems, Inc.

• Simulab Corporation

• Simulaids, Inc.

• Limbs and Things, Ltd.

• Kyoto Kagaku Co. Ltd.

• Mentice AB

• Surgical Science Sweden AB

• Gaumard Scientific Company, Inc.

The other players operating in the medical simulation market include (not profiled in the report)

• MSC

• 3-Dmed

• HRV

• Medical Simulation Technologies sp. z o.o.

• Remedy Simulation Group

• MEDICAL-X

CHAPTER 1: INTRODUCTION

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.4. Research methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top winning strategies

3.2.2. Top investment pockets

3.3. Market share analysis, 2018

3.4. Market dynamics

3.4.1. Impact analyses

3.4.2. Drivers

3.4.2.1. Low expenditure on healthcare

3.4.2.2. Assured improvement in patient safety outcomes

3.4.2.3. Benefits of medical simulation

3.4.2.4. Technological advancements in medical field

3.4.3. Restraints

3.4.3.1. High cost of setting up simulators

3.4.3.2. Limitation of a complete real situation

3.4.4. Opportunities

3.4.4.1. Lucrative opportunities in emerging markets

CHAPTER 4: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE

4.1. Overview

4.1.1. Market size and forecast

4.2. Model-based simulation

4.2.1. Market size and forecast by type

4.2.1.1. Patient simulation

4.2.1.1.1. Market size and forecast

4.2.1.1.1.1. Task trainer simulation: Market Size and Forecast

4.2.1.1.1.2. Manikin-based simulation: Market Size and Forecast

4.2.1.1.1.3. Standardized Patient Simulation: Market Size and Forecast

4.2.1.2. Surgical simulation

4.2.1.2.1. Market size and forecast

4.2.1.2.1.1. Laparoscopic Surgical Simulators: Market Size and Forecast

4.2.1.2.1.2. Arthroscopic Surgical Simulators: Market Size and Forecast

4.2.1.2.1.3. Cardiovascular Simulators: Market Size and Forecast

4.2.1.2.1.4. Gynecology Simulators: Market Size and Forecast

4.2.1.2.1.5. Others: Market Size and Forecast

4.2.1.3. Ultrasound simulation

4.2.1.3.1. Market size and forecast

4.2.2. Market size and forecast, by region

4.2.3. Market analysis, by country

4.3. Web-based simulation

4.3.1. Market size and forecast by type

4.3.1.1. Simulation Software: Market Size and Forecast

4.3.1.2. Performance Recording Software: Market Size and Forecast

4.3.1.3. Virtual Tutors: Market Size and Forecast

4.3.2. Market size and forecast by region

4.3.3. Market analysis, by country

4.4. Simulation Training Services

4.4.1. Market size and forecast by type

4.4.1.1. Vendor-based Training: Market Size and Forecast

4.4.1.2. Custom Consulting Services: Market Size and Forecast

4.4.1.3. Educational Societies: Market Size and Forecast

4.4.2. Market size and forecast by region

4.4.3. Market analysis, by country

CHAPTER 5: MEDICAL SIMULATION MARKET, BY FIDELITY

5.1. Overview

5.1.1. Market size and forecast

5.2. Low-fidelity

5.2.1. Market size and forecast by region

5.2.2. Market analysis, by country

5.3. Medium-fidelity

5.3.1. Market size and forecast by region

5.3.2. Market analysis, by country

5.4. High-fidelity

5.4.1. Market size and forecast by region

5.4.2. Market analysis, by country

CHAPTER 6: MEDICAL SIMULATION MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Academic Institutions & Research Centers

6.2.1. Market size and forecast by region

6.2.2. Market analysis, by country

6.2.2.1. Medical Academia: Market Size and Forecast

6.2.2.2. Nursing: Market Size and Forecast

6.2.2.3. Emergency Medical Services: Market Size and Forecast

6.3. Hospitals & Clinics

6.3.1. Market size and forecast by region

6.3.2. Market analysis, by country

6.4. Military Organizations

6.4.1. Market size and forecast by region

6.4.2. Market analysis, by country

CHAPTER 7: MEDICAL SIMULATION, BY REGION

7.1. Market size and forecast

7.2. North America

7.2.1. North America: Market Size and Forecast, by country

7.2.1.1. U.S. medical simulation: Market Size and Forecast

7.2.1.1.1. U.S. medical simulation: market size and forecast by product & service

7.2.1.1.2. U.S. medical simulation: market size and forecast by fidelity

7.2.1.1.3. U.S. medical simulation: market size and forecast by end user

7.2.1.2. Canada medical simulation: Market Size and Forecast

7.2.1.2.1. Canada medical simulation: market size and forecast by product & service

7.2.1.2.2. Canada medical simulation: market size and forecast by fidelity

7.2.1.2.3. Canada medical simulation: market size and forecast by end user

7.2.1.3. Mexico medical simulation: Market Size and Forecast

7.2.1.3.1. Mexico medical simulation: market size and forecast by product & service

7.2.1.3.2. Mexico medical simulation: market size and forecast by fidelity

7.2.1.3.3. Mexico medical simulation: market size and forecast by end user

7.2.2. North America: market size and forecast by product & service

7.2.3. North America: market size and forecast by fidelity

7.2.4. North America: market size and forecast by end user

7.3. Europe

7.3.1. Europe: Market Size and Forecast, by country

7.3.1.1. Germany medical simulation: Market Size and Forecast

7.3.1.1.1. Germany medical simulation: market size and forecast by product & service

7.3.1.1.2. Germany medical simulation: market size and forecast by fidelity

7.3.1.1.3. Germany medical simulation: market size and forecast by end user

7.3.1.2. France medical simulation: Market Size and Forecast

7.3.1.2.1. France medical simulation: market size and forecast by product & service

7.3.1.2.2. France medical simulation: market size and forecast by fidelity

7.3.1.2.3. France medical simulation: market size and forecast by end user

7.3.1.3. UK medical simulation: Market Size and Forecast

7.3.1.3.1. UK medical simulation: market size and forecast by product & service

7.3.1.3.2. UK medical simulation: market size and forecast by fidelity

7.3.1.3.3. UK medical simulation: market size and forecast by end user

7.3.1.4. Italy medical simulation: Market Size and Forecast

7.3.1.4.1. Italy medical simulation: market size and forecast by product & service

7.3.1.4.2. Italy medical simulation: market size and forecast by fidelity

7.3.1.4.3. Italy medical simulation: market size and forecast by end user

7.3.1.5. Spain medical simulation: Market Size and Forecast

7.3.1.5.1. Spain medical simulation: market size and forecast by product & service

7.3.1.5.2. Spain medical simulation: market size and forecast by fidelity

7.3.1.5.3. Spain medical simulation: market size and forecast by end user

7.3.1.6. Rest of Europe medical simulation: Market Size and Forecast

7.3.1.6.1. Rest of Europe medical simulation: market size and forecast by product & service

7.3.1.6.2. Rest of Europe medical simulation: market size and forecast by fidelity

7.3.1.6.3. Rest of Europe medical simulation: market size and forecast by end user

7.3.2. Europe: market size and forecast by product & service

7.3.3. Europe: market size and forecast by fidelity

7.3.4. Europe: market size and forecast by end user

7.4. Asia-pacific

7.4.1. Asia-pacific: Market Size and Forecast, by country

7.4.1.1. Japan medical simulation: Market Size and Forecast

7.4.1.1.1. Japan medical simulation: market size and forecast by product & service

7.4.1.1.2. Japan medical simulation: market size and forecast by fidelity

7.4.1.1.3. Japan medical simulation: market size and forecast by end user

7.4.1.2. China medical simulation: Market Size and Forecast

7.4.1.2.1. China medical simulation: market size and forecast by product & service

7.4.1.2.2. China medical simulation: market size and forecast by fidelity

7.4.1.2.3. China medical simulation: market size and forecast by end user

7.4.1.3. India medical simulation: Market Size and Forecast

7.4.1.3.1. India medical simulation: market size and forecast by product & service

7.4.1.3.2. India medical simulation: market size and forecast by fidelity

7.4.1.3.3. India medical simulation: market size and forecast by end user

7.4.1.4. Australia medical simulation: Market Size and Forecast

7.4.1.4.1. Australia medical simulation: market size and forecast by product & service

7.4.1.4.2. Australia medical simulation: market size and forecast by fidelity

7.4.1.4.3. Australia medical simulation: market size and forecast by end user

7.4.1.5. Rest of Asia-pacific medical simulation: Market Size and Forecast

7.4.1.5.1. Rest of Asia-pacific medical simulation: market size and forecast by product & service

7.4.1.5.2. Rest of Asia-pacific medical simulation: market size and forecast by fidelity

7.4.1.5.3. Rest of Asia-pacific medical simulation: market size and forecast by end user

7.4.2. Asia-pacific: market size and forecast by product & service

7.4.3. Asia-pacific: market size and forecast by fidelity

7.4.4. Asia-pacific: market size and forecast by end user

7.5. LAMEA

7.5.1. LAMEA: Market Size and Forecast, by country

7.5.1.1. Brazil medical simulation: Market Size and Forecast

7.5.1.1.1. Brazil medical simulation: market size and forecast by product & service

7.5.1.1.2. Brazil medical simulation: market size and forecast by fidelity

7.5.1.1.3. Brazil medical simulation: market size and forecast by end user

7.5.1.2. South Africa medical simulation: Market Size and Forecast

7.5.1.2.1. South Africa medical simulation: market size and forecast by product & service

7.5.1.2.2. South Africa medical simulation: market size and forecast by fidelity

7.5.1.2.3. South Africa medical simulation: market size and forecast by end user

7.5.1.3. Saudi Arabia medical simulation: Market Size and Forecast

7.5.1.3.1. Saudi Arabia medical simulation: market size and forecast by product & service

7.5.1.3.2. Saudi Arabia medical simulation: market size and forecast by fidelity

7.5.1.3.3. Saudi Arabia medical simulation: market size and forecast by end user

7.5.1.4. Rest of LAMEA medical simulation: Market Size and Forecast

7.5.1.4.1. Rest of LAMEA medical simulation: market size and forecast by product & service

7.5.1.4.2. Rest of LAMEA medical simulation: market size and forecast by fidelity

7.5.1.4.3. Rest of LAMEA medical simulation: market size and forecast by end user

7.5.2. LAMEA: market size and forecast by product & service

7.5.3. LAMEA: market size and forecast by fidelity

7.5.4. LAMEA: market size and forecast by end user

CHAPTER 8: COMPANY PROFILES

8.1. 3D SYSTEMS CORPORATION (SIMBIONIX)

8.1.1. Company overview

8.1.2. Company snapshot

8.1.3. Business performance

8.1.4. Key strategic moves and developments

8.2. CAE INC.

8.2.1. Company overview

8.2.2. Company snapshot

8.2.3. Operating business segments

8.2.4. Business performance

8.2.5. Key strategic moves and developments

8.3. GAUMARD SCIENTIFIC COMPANY

8.3.1. Company overview

8.3.2. Company snapshot

8.3.3. Key strategic moves and developments

8.4. KYOTO KAGAKU CO. LTD.

8.4.1. Company overview

8.4.2. Company snapshot

8.4.3. Operating business segments

8.5. LAERDAL MEDICAL AS

8.5.1. Company overview

8.5.2. Company snapshot

8.5.3. Operating business segments

8.5.4. Key strategic moves and developments

8.6. LIMBS AND THINGS LTD.

8.6.1. Company overview

8.6.2. Company snapshot

8.6.3. Operating business segments

8.6.4. Key strategic moves and developments

8.7. MENTICE AB

8.7.1. Company overview

8.7.2. Company snapshot

8.7.3. Operating business segments

8.7.4. Key strategic moves and developments

8.8. SIMULAB CORPORATION

8.8.1. Company overview

8.8.2. Company snapshot

8.8.3. Operating business segments

8.9. SIMULAIDS INC.

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Operating business segments

8.9.4. Key strategic moves and developments

8.10. SURGICAL SCIENCE SWEDEN AB

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Business performance

8.10.4. Key strategic moves and developments

LIST OF TABLES

TABLE 01. GLOBAL MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 02. GLOBAL MODEL-BASED SIMULATION MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 03. GLOBAL PATIENT SIMULATION MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 04. GLOBAL SURGICAL SIMULATION MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 05. GLOBAL MODEL-BASED MEDICAL SIMULATION MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)

TABLE 06. GLOBAL WEB-BASED MEDICAL SIMULATION MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 07. WEB-BASED MEDICAL SIMULATION MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)

TABLE 08. GLOBAL SIMULATION TRAINING SERVICES MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 09. SIMULATION TRAINING SERVICES MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)

TABLE 10. GLOBAL MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 11. LOW-FIDELITY SIMULATION MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)

TABLE 12. MEDIUM-FIDELITY SIMULATION MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)

TABLE 13. HIGH-FIDELITY SIMULATION MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)

TABLE 14. GLOBAL MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 15. MEDICAL SIMULATION MARKET REVENUE FOR ACADEMIC INSTITUTIONS & RESEARCH CENTERS, BY REGION, 2017–2025 ($MILLION)

TABLE 16. MEDICAL SIMULATION MARKET REVENUE FOR HOSPITALS & CLINICS, BY REGION, 2017–2025 ($MILLION)

TABLE 17. MEDICAL SIMULATION MARKET REVENUE FOR MILITARY ORGANIZATIONS, BY REGION, 2017–2025 ($MILLION)

TABLE 18. MEDICAL SIMULATION MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)

TABLE 19. NORTH AMERICA MEDICAL SIMULATION MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 20. U.S. MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 21. U.S. MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 22. U.S. MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 23. CANADA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 24. CANADA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 25. CANADA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 26. MEXICO MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 27. MEXICO MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 28. MEXICO MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 29. NORTH AMERICA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 30. NORTH AMERICA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 31. NORTH AMERICA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 32. EUROPE MEDICAL SIMULATION MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 33. GERMANY MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 34. GERMANY MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 35. GERMANY MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 36. FRANCE MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 37. FRANCE MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 38. FRANCE MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 39. UK MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 40. UK MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 41. UK MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 42. ITALY MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 43. ITALY MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 44. ITALY MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 45. SPAIN MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 46. SPAIN MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 47. SPAIN MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 48. REST OF EUROPE MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 49. REST OF EUROPE MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 50. REST OF EUROPE MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 51. EUROPE MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 52. EUROPE MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 53. EUROPE MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 54. ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 55. JAPAN MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 56. JAPAN MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 57. JAPAN MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 58. CHINA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 59. CHINA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 60. CHINA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 61. INDIA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 62. INDIA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 63. INDIA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 64. AUSTRALIA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 65. AUSTRALIA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 66. AUSTRALIA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 67. REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 68. REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 69. REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 70. ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 71. ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 72. ASIA-PACIFIC MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 73. LAMEA MEDICAL SIMULATION MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 74. BRAZIL MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 75. BRAZIL MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 76. BRAZIL MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 77. SOUTH AFRICA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 78. SOUTH AFRICA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 79. SOUTH AFRICA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 80. SAUDI ARABIA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 81. SAUDI ARABIA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 82. SAUDI ARABIA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 83. REST OF LAMEA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 84. REST OF LAMEA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 85. REST OF LAMEA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 86. LAMEA MEDICAL SIMULATION MARKET REVENUE, BY PRODUCT & SERVICE, 2017–2025 ($MILLION)

TABLE 87. LAMEA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2017–2025 ($MILLION)

TABLE 88. LAMEA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 89. 3D SYSTEMS: COMPANY SNAPSHOT

TABLE 90. CAE: COMPANY SNAPSHOT

TABLE 91. CAE: OPERATING SEGMENTS

TABLE 92. GAUMARD: COMPANY SNAPSHOT

TABLE 93. KYOTO KAGAKU: COMPANY SNAPSHOT

TABLE 94. KYOTO KAGAKU: OPERATING SEGMENTS

TABLE 95. LAERDAL: COMPANY SNAPSHOT

TABLE 96. LAERDAL: OPERATING SEGMENTS

TABLE 97. LIMBS & THINGS: COMPANY SNAPSHOT

TABLE 98. LIMBS & THINGS: OPERATING SEGMENTS

TABLE 99. MENTICE: COMPANY SNAPSHOT

TABLE 100. MENTICE: OPERATING SEGMENTS

TABLE 101. SIMULAB: COMPANY SNAPSHOT

TABLE 102. SIMULAB: OPERATING SEGMENTS

TABLE 103. SIMULAIDS: COMPANY SNAPSHOT

TABLE 104. SIMULAIDS: OPERATING SEGMENTS

TABLE 105. SURGICAL SCIENCE: COMPANY SNAPSHOT

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370